MACQUARIE GROUP LTD - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$509,000
-25.1%
380,0000.0%0.00%0.0%
Q2 2023$680,000
-54.0%
380,0000.0%0.00%
-50.0%
Q1 2023$1,478,000
+14.4%
380,0000.0%0.00%0.0%
Q4 2022$1,292,000
-38.1%
380,000
-0.4%
0.00%
-33.3%
Q3 2022$2,086,000
+21.1%
381,465
-0.2%
0.00%
+50.0%
Q2 2022$1,723,000
-38.8%
382,0410.0%0.00%0.0%
Q1 2022$2,816,000
+14.7%
382,0410.0%0.00%0.0%
Q4 2021$2,456,000
+10.4%
382,0410.0%0.00%0.0%
Q3 2021$2,224,000
-43.6%
382,0410.0%0.00%
-33.3%
Q2 2021$3,943,000
-1.6%
382,041
+0.3%
0.00%
-50.0%
Q1 2021$4,009,000
-32.1%
381,059
-0.1%
0.01%
-33.3%
Q4 2020$5,903,000
+6.0%
381,3320.0%0.01%0.0%
Q3 2020$5,567,000
-22.9%
381,3320.0%0.01%
-25.0%
Q2 2020$7,222,000
-1.1%
381,332
+0.4%
0.01%
-20.0%
Q1 2020$7,300,000
+0.2%
380,0000.0%0.02%
+50.0%
Q4 2019$7,285,000
+99.3%
380,0000.0%0.01%
+66.7%
Q3 2019$3,656,000
-46.5%
380,000
-66.7%
0.01%
+50.0%
Q2 2019$6,828,000
+207.7%
1,140,000
+200.0%
0.00%0.0%
Q1 2019$2,219,000
-37.7%
380,000
-0.1%
0.00%
-42.9%
Q4 2018$3,564,000
-38.1%
380,300
+12.4%
0.01%
-22.2%
Q3 2018$5,759,000
-0.5%
338,200
-0.7%
0.01%
-10.0%
Q2 2018$5,787,000
+64200.0%
340,600
+37744.4%
0.01%
Q4 2017$9,0009000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders